CytomX Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2019 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CytomX Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to 2023.
  • CytomX Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 85.1M shares, a 5.4% increase year-over-year.
  • CytomX Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 73.8M shares, a 12.3% increase from 2022.
  • CytomX Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 65.7M shares, a 2.48% increase from 2021.
  • CytomX Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 64.1M shares, a 39% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 73.8M +8.07M +12.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 65.7M +1.59M +2.48% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 64.1M +18M +39% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 46.1M +810K +1.79% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-03-27
2019 45.3M Jan 1, 2019 Dec 31, 2019 10-K/A 2023-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.